510(k) · Cleared
ClearedCedia Cardiac TDM Multi-Cals
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Boehringer Mannheim Corp. · JIX Calibrator, Multi-Analyte Mixture
Cleared on Oct 29, 1996 as substantially equivalent to K910642 (Microgenics Corp., 1991) and 2 other predicates after a 138-day review. Its family tree reaches back 1 generation to 1983. 1 later device descends from it.
- Decided
- Oct 29, 1996
- Review
- 138 days
- Class
- Class II
- Product code
- JIX
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 1 generation to K830206 (1983). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K972433Cedia Digoxin CalibratorsBoehringer Mannheim Corp. · 1997 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K830206 | TDX N-Acetylprocainamide | Abbott Laboratories | 1983 | — |
| 0 (this device) | K962269 | Cedia Cardiac TDM Multi-Cals | Boehringer Mannheim Corp. | 1996 | — |
| +1 | K972433 | Cedia Digoxin Calibrators | Boehringer Mannheim Corp. | 1997 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1984 | 1 | 0 |
| 1991 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JIX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K910642 | Cedia (R) Digoxin SC AssaySummary page 1…tion name: Calibrators, drug mixture The Boehringer Mannheim CEDIA Cardiac TDM Multi-Cals are substantially equivalent to the kit calibrators included in CEDIA Digoxin (K910642), TDx Procainamide (K834464), and TDx N-acetylproceinamide (K830206) Assays. The CEDIA Cardiac TDM Calibrators are manufactured… | 1991 |
| * | K834464 | TDX ProcainamideSummary page 1…mixture The Boehringer Mannheim CEDIA Cardiac TDM Multi-Cals are substantially equivalent to the kit calibrators included in CEDIA Digoxin (K910642), TDx Procainamide (K834464), and TDx N-acetylproceinamide (K830206) Assays. The CEDIA Cardiac TDM Calibrators are manufactured using bovine serum albumin,… | 1984 |
| * | K830206 | TDX N-AcetylprocainamideSummary page 1…Cardiac TDM Multi-Cals are substantially equivalent to the kit calibrators included in CEDIA Digoxin (K910642), TDx Procainamide (K834464), and TDx N-acetylproceinamide (K830206) Assays. The CEDIA Cardiac TDM Calibrators are manufactured using bovine serum albumin, digoxin, N-acetylprocainamide, procainam… | 1983 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K972433 | Cedia Digoxin Calibrators | 1997 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 3 ancestors has a recall.
- Of its descendants, K972433 (Boehringer Mannheim Corp., 1997) has gone furthest, with 0 descendants of its own.
How does its category compare?
All JIX devicesJIX Calibrator, Multi-Analyte Mixture: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JIX
1in 2016
2026 to Oct 25, outlined.
Median 510(k) review, days · JIX
29in 2015
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JIX
7in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JIX
18in 2025
MAUDE reports naming product code JIX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 53 | 2 | 140 |
| 2008 | 5 | 69 | 3 | 173 |
| 2009 | 4 | 121 | 2 | 39 |
| 2010 | 5 | 100 | 1 | 0 |
| 2011 | 7 | 77 | 2 | 9 |
| 2012 | 2 | — | 1 | 3 |
| 2013 | 4 | 50 | 0 | 24 |
| 2014 | 1 | — | 1 | 35 |
| 2015 | 3 | 29 | 0 | 4 |
| 2016 | 1 | — | 1 | 6 |
| 2017 | 0 | — | 1 | 17 |
| 2018 | 0 | — | 1 | 16 |
| 2019 | 0 | — | 1 | 12 |
| 2020 | 0 | — | 2 | 22 |
| 2021 | 0 | — | 0 | 9 |
| 2022 | 0 | — | 0 | 11 |
| 2023 | 0 | — | 7 | 13 |
| 2024 | 0 | — | 0 | 15 |
| 2025 | 0 | — | 0 | 18 |
| 2026 | 0 | — | 1 | — |
What is it indicated for?
The CEDIA Cardiac TDM Multi-Cals are used to calibrate the CEDIA assays for digoxin, N-acetylprocainamide, and procainamide, in human serum and plasma.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K962269 · printed Nov 6, 2026
Cite this page
510(k) Report. “K962269: Cedia Cardiac TDM Multi-Cals.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K962269
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026